Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:87
  • preuzimanja u poslednjih 30 dana:14

Sadržaj

članak: 1 od 1  
2020, vol. 70, br. 6, str. 332-343
Uloga prava intelektualne svojine i sigurnosnih karakteristika pakovanja u prevenciji falsifikovanih lekova
aUniversity "Ss. Cyril and Methodius", Faculty of Pharmacy, Institute of Pharmaceutical Chemistry, Skopje, Republic of North Macedonia
bUniversity "Ss. Cyril and Methodius", Faculty of Pharmacy, Institute of Applied Chemistry and Pharmaceutical Analysis, Skopje, Republic of North Macedonia
cUniversity "Ss. Cyril and Methodius", Faculty of Pharmacy, Institute of Pharmaceutical Technology, Skopje, Republic of North Macedonia

e-adresakaan@ff.ukim.edu.mk, kago@ff.ukim.edu.mk
Ključne reči: prava intelektualne svojine; falsifikovanje; lekovi; pakovanje lekova
Sažetak
Brzi rast falsifikovanih lekova u poslednje dve decenije stvorio je jedan od najvećih problema sa kojima se susreće farmaceutska industrija na globalnom nivou, što dovodi do gubitka prihoda, povlačenje proizvoda, gubitak vrednosti brenda itd. Međutim, ovo nije samo problem prava intelektualne svojine farmaceutske industrije, već je isto tako i problem regulatornih organa, čija najznačajnija obaveza je rizik javnog zdravlja. Proizvođači farmaceutskih proizvoda, zajedno sa distributerima, imaju bitnu ulogu u borbi protiv falsifikovanih lekova primenom različitih antifalsifikovanih tehnologija za obezbeđenje lanca snabdevanja lekovima. Zaštita pakovanja lekova ima i specifičnu ulogu u procesu ravoja lekova, kao i u borbi protiv falsifikovanih lekova. Autentičnost leka i forenzičkih elemenata za zaštitu pakovanja mogu se potvrditi upotrebom različitih tehnologija. Praćenje i pronalaženje farmaceutskih proizvoda u lancu snabdevanja , vođenje elektronske evidencije svih faza distribucije i provera autentučnosti leka je ključni element i efikasno rešenje za pravovremeno otkrivanje falsifikovanih lekova i zaštite prava intelektualne svojine.
Reference
*** (2020) Trade in counterfeit pharmaceutical products. Paris: OECD Publishing, (Illicit Trade)
*** Thermochromic ink ensures safety of pharmaceutical products. [Internet]
Agrawal, Y.K., Shah, R.Y., Prajapati, P.N. (2010) Anticounterfeit packaging technologies. Journal of Advanced Pharmaceutical Technology & Research, 1(4): 368
Bauer, E.J. (2016) Pharmaceutical packaging handbook. Boca Raton, FL: CRC Press, 1-585
Clark, F. (2015) Rise in online pharmacies sees counterfeit drugs go global. Lancet, 386(10001): 1327-1328; Lancet Publishing Group
Cockburn, I., Long, G. (2015) The importance of patents to innovation: Updated cross-industry comparisons with biopharmaceuticals. Expert Opinion on Therapeutic Patents, 25(7): 739-742
Council of Europe (2013) Ad hoc group on counterfeit medicines (P-SP-PH/CMED) national and international co-operation to combat counterfeiting of medicines and pharmaceutical crimes: A model for a network and single points of contact (spocs). Brussels
Council of Europe (2001) Directive 2011/62/EU of the European Parliament and of the council of 8 June 2011 amending directive 2001/83/EC on the community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of. Brussels
Davison, M. (2011) Pharmaceutical anti-counterfeiting: Combating the real danger from fake drugs. Hoboken, NJ: John Wiley and Sons
European Commision Falsified medicines. Public Health [Internet]
European Commision (2016) Ommission delegated regulation (EU) 2016/ 161 -of 2 October 2015: Supplementing directive 2001/ 83/ EC of the European Parliament and of the council by laying down detailed rules for the safety features appearing on the packaging of medicinal product. Brussels
Imlau, M., Fally, M., Coufal, H., Burr, G., Sincerbox, G. (2007) Springer handbook of lasers and optics. u: Springer Handbook of Lasers and Optics, New York: Springer, 1205-1254
Jallouli, Y., Paillard, A., Chang, J., Sevin, E., Betbeder, D. (2007) Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. International Journal of Pharmaceutics, 344(1-2): 103-109
Kortum, P., Edwards, C., Richards-Kortum, R. (2008) The impact of inaccurate internet health information in a secondary school learning environment. Journal of Medical Internet Research, 10(2)
Kovacs, S., Hawes, S.E., Maley, S.N., Mosites, E., Wong, L., Stergachis, A. (2014) Technologies for detecting falsified and substandard drugs in low and middle-income countries. PLoS One, 9(3): e90601; Sullivan D.J., editor
Medicines and Healthcare Products Regulatory Agency (MHRA) (2012) Falsified medical products strategy 2012-2015. London
Saha, N.C., Bhattacharya, S. Intellectual property rights: An overview and implications in pharmaceutical industry. Journal of Advanced Pharmaceutical Technology and Research, vol. 2
Therapeutic Goods Administration (2003) Code of practice for the tamper-evident packaging (TEP) of therapeutic goods published on behalf of the industry government crisis management committee (IGCMC) about the therapeutic goods administration (TGA). Woden
Wijnberg, B. (2013) Counterfeiting of medical products and similar crimes: 'Medicrime'. Strasbourg: Council of Europe
World Health Organization (WHO) (1999) Counterfeit drugs: Guidelines for the development of measures to combat counterfeit drugs. Geneva
World Health Organization (WHO) (2006) Conclusions and recommendations of the who international conference on combating countefeit medicines. Rome, Declaration of Rome; Feb
World Health Organization (WHO) (2002) Annex 9 guidelines on packaging for pharmaceutical products. Geneva
Wouters, O.J., Kanavos, P.G., McKee, M. (2017) Comparing generic drug markets in Europe and the United States: Prices, volumes, and spending. Milbank Quarterly, 95(3): 554-601
Zadbuke, N., Shahi, S., Gulecha, B., Padalkar, A., Thube, M. (2013) Recent trends and future of pharmaceutical packaging technology. Journal of Pharmacy and Bioallied Sciences, 5(2): 98-110; Wolters Kluwer --Medknow Publications
 

O članku

jezik rada: engleski
vrsta rada: pregledni članak
DOI: 10.5937/arhfarm70-28974
objavljen u SCIndeksu: 12.01.2021.
metod recenzije: jednostruko anoniman
Creative Commons License 4.0

Povezani članci

Nema povezanih članaka